Press Releases on July 29, 2024 - EIN Presswire - Press Release Distribution Service

Published on July 29, 2024 - 12:00 GMT

Ventyx Biosciences Announces Results from the Phase 2 Trial of VTX958 in Participants with Moderately to Severely Active Crohn’s ...

The Phase 2 trial of VTX958 in Crohn’s disease did not meet its primary endpoint of change from baseline in mean CDAI score in either VTX958 dose group Both VTX958 dose groups achieved nominal statistical significance on the key secondary endpoint of …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on July 29, 2024 - 12:00 GMT

Loadsmart Announces SOC 2 Type II Compliance

Chicago, IL, July 29, 2024 (GLOBE NEWSWIRE) -- Loadsmart, a leading logistics solutions provider, has announced its successful achievement of SOC 2 Type II compliance in Security, Availability, and Confidentiality. Successful SOC 2 Type II compliance not …

Distribution channels: Media, Advertising & PR, Shipping, Storage & Logistics ...

Published on July 29, 2024 - 12:00 GMT

Hopebridge Partners with EarliTec Dx to Provide Objective Autism Assessment for Children up to Age 30 Months

ATLANTA, GA, July 29, 2024 (GLOBE NEWSWIRE) -- Atlanta families of young children now have opportunities for more objective evaluations for autism spectrum disorder (ASD) as part of Hopebridge Autism Therapy Centers’ partnership with EarliTec Diagnostics …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on July 29, 2024 - 12:00 GMT

PDS Biotech to Participate at BTIG Virtual Biotechnology Conference

PRINCETON, N.J., July 29, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers and the development …

Distribution channels:

Published on July 29, 2024 - 12:00 GMT

CervoMed Announces Presentation at AAIC 2024 on Plasma Biomarker Data That Are Consistent with Neflamapimod Impacting the ...

- Baseline data from the AscenD-LB Phase 2a trial in DLB demonstrated that plasma glial fibrillary acidic protein (GFAP) was highly correlated to scores on the CDR-SB; plasma GFAP shown to increase with neurodegenerative progression in DLB – - AscenD-LB …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on July 29, 2024 - 12:00 GMT

Kratos Defense & Security Solutions Schedules Second Quarter 2024 Earnings Conference Call for Wednesday, August 7th

SAN DIEGO, July 29, 2024 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS), a Technology Company in the Defense, National Security and Global Markets, announced today that it will publish financial results for the second …

Distribution channels:

Published on July 29, 2024 - 12:00 GMT

Star Group, L.P. to Host Fiscal 2024 Third Quarter Webcast and Conference Call August 1, 2024

STAMFORD, Conn., July 29, 2024 (GLOBE NEWSWIRE) -- Star Group, L.P. (the “Company” or “Star”) (NYSE: SGU), a leading home energy distributor and services provider, today announced that it will release its fiscal 2024 third quarter results after the close …

Distribution channels:

Published on July 29, 2024 - 12:00 GMT

NewAmsterdam Pharma Announces Positive Topline Data from Pivotal Phase 3 BROOKLYN Clinical Trial Evaluating Obicetrapib in ...

-- Achieved primary endpoint of LS mean reduction in LDL-C on top of maximally tolerated lipid modifying therapies at day 84 with statistically significant reduction (p<0.0001), which was sustained at day 365 (p<0.0001) -- -- Obicetrapib lowered LDL- …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on July 29, 2024 - 12:00 GMT

Grifols receives expanded XEMBIFY® (immune globulin subcutaneous human-klhw) label in U.S., strengthening its Ig portfolio for ...

XEMBIFY is the first and only 20% subcutaneous immunoglobulin (SCIg) with FDA-approved dosing for treatment-naïve patients, enabling them to go straight to SCIg without initial intravenous therapy Approval, which also includes biweekly dosing, follows …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on July 29, 2024 - 12:00 GMT

Monarch Private Capital Welcomes Industry Veterans to Bolster Asset Management Team

ATLANTA, July 29, 2024 (GLOBE NEWSWIRE) -- Monarch Private Capital (Monarch), a nationally recognized impact investment firm that develops, finances and manages a diversified portfolio of projects generating both federal and state tax credits, is excited …

Distribution channels: Banking, Finance & Investment Industry, Companies ...

Published on July 29, 2024 - 12:00 GMT

MediWound Announces Publication of the EscharEx® Phase II ChronEx Study Results for Venous Leg Ulcers

Research Published in THE LANCET's eClinicalMedicine EscharEx® Outperforms Non-Surgical Standard of Care in Debridement and Promotion of Healthy Granulation Tissue YAVNE, Israel, July 29, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), the …

Distribution channels: Technology ...

Published on July 29, 2024 - 12:00 GMT

ConnectWise Appoints Aziz Benmalek as Chief Business Officer

TAMPA, Fla., July 29, 2024 (GLOBE NEWSWIRE) -- ConnectWise, the leading software company dedicated to the success of Managed Service Providers (MSPs), is pleased to announce the appointment of Aziz Benmalek as its new Chief Business Officer (CBO). In this …

Distribution channels:

Published on July 29, 2024 - 12:00 GMT

California BanCorp Reports Financial Results for the Second Quarter and Six Months Ended June 30, 2024

OAKLAND, Calif., July 29, 2024 (GLOBE NEWSWIRE) -- California BanCorp (NASDAQ: CALB) (the “Company”), whose subsidiary is California Bank of Commerce, announced today its financial results for the second quarter and six months ended June 30, 2024. The …

Distribution channels:

Published on July 29, 2024 - 12:00 GMT

Asset Entities Inc. Regains Compliance with Nasdaq

DALLAS, July 29, 2024 (GLOBE NEWSWIRE) -- Asset Entities Inc. (“Asset Entities” or “the Company”) (NASDAQ: ASST), a provider of digital marketing and content delivery services across Discord and other social media platforms, and a Ternary Payment Platform …

Distribution channels: Banking, Finance & Investment Industry ...

Published on July 29, 2024 - 12:00 GMT

iCAD and Windsong Radiology Announce Strategic Commercial Agreement to Implement AI-Powered Mammography

NASHUA, N.H. and WILLIAMSVILLE, N.Y. and RALEIGH, N.C., July 29, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader in clinically proven AI-powered cancer detection solutions, today announced a strategic agreement with Windsong Radiology …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on July 29, 2024 - 12:00 GMT

Ceylon Graphite Enters Into Purchase and Distribution Agreement with GES Europe

Vancouver, BC, July 29, 2024 (GLOBE NEWSWIRE) -- Ceylon Graphite Corp. ("Ceylon") (TSX-V: CYL) (OTC: CYLYF) (FSE: CCY) is pleased to announce it has entered into a purchase and distribution agreement with GES Europe GmbH (“GES”), www.geseurope.de …

Distribution channels: Media, Advertising & PR, Mining Industry ...

Published on July 29, 2024 - 12:00 GMT

Alumis Initiates ONWARD Phase 3 Clinical Program Evaluating ESK-001, an Oral TYK2 Inhibitor, in Moderate-to-Severe Plaque ...

– Co-primary endpoint of PASI 75 and sPGA 0/1 score at 24 weeks to serve as basis for U.S. regulatory submission – – Pivotal Phase 3 program supported by positive Phase 2 STRIDE clinical data as well as ongoing open-label extension (OLE) study – – Topline …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on July 29, 2024 - 12:00 GMT

DZS to Demonstrate Groundbreaking Remote In-Band Management Capabilities for 100G/400G Optical Transport at Fiber Connect 2024

DALLAS and NASHVILLE, Tenn., July 29, 2024 (GLOBE NEWSWIRE) -- DZS (Nasdaq: DZSI), a developer of Network Edge, Connectivity and Cloud Software solutions enabling gigabit broadband everywhere, today announced another milestone in its mission to …

Distribution channels: Culture, Society & Lifestyle, Media, Advertising & PR ...

Published on July 29, 2024 - 12:00 GMT

Hummingbird Bioscience Announces Key Leadership Appointments

Kon Yew Kwek, BM BCh, DPhil, appointed Chief Medical Officer Lisa Ooi, PhD, appointed Chief Operating Officer SAN FRANCISCO and SINGAPORE, July 29, 2024 (GLOBE NEWSWIRE) -- Hummingbird Bioscience, a precision biotherapeutics company discovering and …

Distribution channels: Companies, Technology ...

Published on July 29, 2024 - 12:00 GMT

Achieve Life Sciences Announces $20M Loan Refinancing with Silicon Valley Bank

SEATTLE and VANCOUVER, British Columbia, July 29, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...